BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17624531)

  • 1. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
    Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
    Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation.
    Alvarenga EM; Souza LK; Araújo TS; Nogueira KM; Sousa FB; Araújo AR; Martins CS; Pacífico DM; de C Brito GA; Souza EP; Sousa DP; Medeiros JV
    Chem Biol Interact; 2016 Dec; 260():129-140. PubMed ID: 27838229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the tumour necrosis factor-alpha inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters.
    Lima V; Brito GA; Cunha FQ; Rebouças CG; Falcão BA; Augusto RF; Souza ML; Leitão BT; Ribeiro RA
    Eur J Oral Sci; 2005 Jun; 113(3):210-7. PubMed ID: 15953245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
    Pereira VB; Melo AT; Assis-Júnior EM; Wong DV; Brito GA; Almeida PR; Ribeiro RA; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):323-32. PubMed ID: 26666645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis.
    Hu ZP; Yang XX; Chan SY; Xu AL; Duan W; Zhu YZ; Sheu FS; Boelsterli UA; Chan E; Zhang Q; Wang JC; Ee PL; Koh HL; Huang M; Zhou SF
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):225-37. PubMed ID: 17015070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.
    de Araújo AA; Borba PB; de Souza FH; Nogueira AC; Saldanha TS; Araújo TE; da Silva AI; de Araújo Júnior RF
    Biol Pharm Bull; 2015; 38(5):746-52. PubMed ID: 25947920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel model of megavoltage radiation-induced oral mucositis in hamsters: Role of inflammatory cytokines and nitric oxide.
    Moura JF; Mota JM; Leite CA; Wong DV; Bezerra NP; Brito GA; Lima V; Cunha FQ; Ribeiro RA
    Int J Radiat Biol; 2015 Jun; 91(6):500-9. PubMed ID: 25758466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
    Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: Role for peripheral TNFα, IL-1β and IL-10.
    Carvalho TT; Borghi SM; Pinho-Ribeiro FA; Mizokami SS; Cunha TM; Ferreira SH; Cunha FQ; Casagrande R; Verri WA
    Eur J Pharmacol; 2015 Feb; 749():62-72. PubMed ID: 25584775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor.
    Yang XX; Hu ZP; Xu AL; Duan W; Zhu YZ; Huang M; Sheu FS; Zhang Q; Bian JS; Chan E; Li X; Wang JC; Zhou SF
    J Pharmacol Exp Ther; 2006 Oct; 319(1):82-104. PubMed ID: 16815871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan decreased levels of IL-1β and TNF-α, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis model.
    de Araújo RF; Reinaldo MP; Brito GA; Cavalcanti Pde F; Freire MA; de Medeiros CA; de Araújo AA
    PLoS One; 2014; 9(12):e114923. PubMed ID: 25531650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.
    Kato S; Hayashi S; Kitahara Y; Nagasawa K; Aono H; Shibata J; Utsumi D; Amagase K; Kadowaki M
    PLoS One; 2015; 10(1):e0116213. PubMed ID: 25565296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
    Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
    Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.
    Wong DV; Lima-Júnior RC; Carvalho CB; Borges VF; Wanderley CW; Bem AX; Leite CA; Teixeira MA; Batista GL; Silva RL; Cunha TM; Brito GA; Almeida PR; Cunha FQ; Ribeiro RA
    PLoS One; 2015; 10(10):e0139985. PubMed ID: 26440613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
    Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
    BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side-Effects of Irinotecan (CPT-11), the Clinically Used Drug for Colon Cancer Therapy, Are Eliminated in Experimental Animals Treated with Latex Proteins from Calotropis procera (Apocynaceae).
    de Alencar NM; da Silveira Bitencourt F; de Figueiredo IS; Luz PB; Lima-Júnior RC; Aragão KS; Magalhães PJ; de Castro Brito GA; Ribeiro RA; de Freitas AP; Ramos MV
    Phytother Res; 2017 Feb; 31(2):312-320. PubMed ID: 27910140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide.
    Yang XX; Hu ZP; Chan SY; Duan W; Ho PC; Boelsterli UA; Ng KY; Chan E; Bian JS; Chen YZ; Huang M; Zhou SF
    Curr Drug Metab; 2006 May; 7(4):431-55. PubMed ID: 16724931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.